Onus now on UK research & development industry to demonstrate "cybrid" stem cell potential
This article was originally published in Clinica
Executive Summary
"It's down to you: prove that your project is necessary and desirable!" That's the bottom line for the UK's biomedical technology R&D community, on its plans to dramatically expand its capacity to explore the potential of embryonic stem cells through hybridisation.